Board of Director's Operating Report for Financial Statement At

Total Page:16

File Type:pdf, Size:1020Kb

Board of Director's Operating Report for Financial Statement At Board of Director’s Operating Report for Financial Statement at December 31, 2008 126 Financial Statement 2008 - Management Report Shareholders, The 2008 financial statements, prepared on the basis of IAS/IFRS international accounting standards, report on your company’s twenty-eighth year in business, closing with a profit of 21.2 million euro (+ 18.7% over 2007), after payment of 7.8 million Euro in taxes. R.O.E. was 27.40%, significantly higher than in 2007 (24.05%). On the topic of competitive positioning, note that in 2008 the company ranked fifth in its sector in terms of outstanding credit, with a market share of 6.0%, and fourth in terms of advances and payments made, with a market share of 6.7% (source: Assifact). The annual profit, though it did reflect the effects of certain non-recurrent events, is definitely noteworthy in terms of management of regular operations. In the year 2008 profit margins reflected replacement of about 3.0 million Euro in gains from purchases of credit not at face value (now a residual activity), which were entered under “Other operating income” in 2007, with profit margins from characteristic operations, marking the completion of the commercial strategy undertaken since 2006 aiming to improve performance on the working capital market for customer companies, the number of which has definitely grown (+ 43% active transferring customers). The Operating Margin was 49.2 million euro, up 12.4% over 2007. This performance is primarily attributable to Interest Margin dynamics, which have settled at 34.0 million euro (+26.4% over 2007), while Net Commissions were worth 15.2 million euro (-10.0 % since 2007). Financial performance is attributable to the interest rate dynamic and to a market scenario characterised by widespread shrinkage of the availability of funds. The decision to reduce business with the public sector and the decision to leave high risk market sectors which earned high commissions also explain the reduction in revenues from commissions. Events of significance in regular operations and non-recurrent events included: a) the positive impact of redemption of extra-accounting deductions from “Quadro EC”, permitted under Law 244/2007 (2008 Budget), with a net fiscal benefit of 2.3 million Euro in terms of lower deferred taxes; b) resumption of the Risks and Charges Fund for provisions set aside in previous years for the Parmalat revocatory action, recently settled with signature of a settlement agreement, resulting in release of about Euro 2.0 million from this fund and contributing the same amount to annual net profit. 2008 was characterised by strong growth among customers of the UBI Banca banking group, leading to satisfactory results in terms of volumes but not yet in terms of revenues, as a result of the transactions conducted (guarantees without financing), the clientele selected (Retail and Lower Corporate) and pricing policies, 127 Financial Statement 2008 - Management Report which are initially still aligned with those applied by the bank. This resulted in an Operating Margin on Turnover of 0.37%, far from the expected percentage of 0.76%. Significant initiatives were therefore undertaken in the last quarter of the year: re- pricing of clientele in terms of commissions and a project in collaboration with the parent company aimed at intensifying synergies with banks through a targeted commercial approach, assigning internal bank staff and implementing pricing policies specifically tailored to different segments of the clientele. These actions are expected to produce substantial economic and commercial effects in 2009. World-wide recession has had a significant impact on commercial action, resulting in progressive withdrawal from companies in high risk sectors (such as consumer electronics, construction and textiles) and shrinkage of volumes and revenues from economic groups with which we have specific agreements. Business with the Electrolux Group decreased by an average of 20%, continuing into the month of January 2009. On the other hand, our commercial policy of setting up business partnerships or agreements with companies of high standing continued with the goal of undertaking initiatives capable of guaranteeing significant ongoing volumes of business. An agreement was signed with the Rosso Group, which established the company Incentive Factor. In the public sector, we continued our policy of optimisation aimed at reducing the impact of this business area on the company’s revenues through a number of operations which attempted to reduce exposure toward the Region of Lazio in particular. This process will be completed in April 2009 with collection of a large number of credits. Finally, our international activities continue to grow, based on export and import factoring operations aimed at developing relations with customers of high standing, characterised by good profitability with a very low credit risk, working on both mature and developing markets. In this regard we wish to note the opening of a Polish Branch in Krakow in the last quarter of 2008 and a business partnership with Turkish factoring company Strateji Factoring Hizmetleri A.Ş. which generated a turnover of more than 7 million euro and revenues of about euro 230 thousand in 2008. Following the opening of the UBI Factor S.p.A. branch in Poland (Krakow), all activities preparatory to development of captive factoring operations for the Electrolux and Marcegaglia Group supplier pool were completed, and about 8 million euro in transactions were conducted with Polish suppliers of the FIAT Group; the branch office received operating regulations and was provided with a sufficient number of employees for internal development activities, working in a close partnership with our Pordenone operating unit, which acts as Deputy Manager. Cost/Income was 39.95%, as compared to 44.21% in the previous year, a variation of -4.26 percentage points. Administrative costs were decreased for the second year in a row, settling at Euro 20.5 million (-5.1%). Total turnover from transactions in the year was 5,511.0 million Euro (+12.3% over 2007). Credits to customers totalled 2,133.9 million Euro, up 10.9% over the year 2007 (1,924.1 million Euro). 128 Financial Statement 2008 - Management Report Net non-performing assets due to outstanding credits total 5.1 million euro (3.1 million euro on 31/12/2007), representing 0.24% of all loans, with a coverage of 65%, and impaired credits total 7.5 million euro (6.4 million euro on 31/12/2007), representing 0.35% of all loans. It is also worth noting that impaired items mainly represent credits acquired from the public sector, and more specifically from Institutional Commissarial Operations, the residual duration of which upon collection suggested that they be assigned to this credit category but which certainly does not question their full collectability. Adjustments of the value of analytic entries on credits, worth 3.9 million euro, are considered congruous, on the basis of prudent assessments performed taking into account their total value and market trends. The year 2008 saw the liquidation of Financiera Veneta. This generated 1.3 million Euro in gains, recorded under the Shareholders’ Equity Reserve, after subtraction of deferred taxation. In 2008 the company also purchased 1% of the share capital of UBI Sistemi e Servizi, effective April 24 2008. On the content of Banca d’Italia/CONSOB /ISVAP Documento n° 2 dated February 6 2009, Banca d’Italia, Consob and ISVAP Coordination Table for application of IAS/IFRS, on the subject of “Information to be supplied in financial reports on continuity of business, financial risks, audits due to reduction of the value of assets and uncertainties in the use of estimates”, combined with the provisions of section 2428 of the Civil Code, note that the company is, at present, capable of continuing its operative existence in the foreseeable future and the financial statements that follow are compatible with this assumption. In view of the variety of factors contributing to current and expected future profitability, the plan of payments and collections from contractual counterparts, and the source of financing – primarily the parent company UBI Banca – your company does not at present have any doubt or uncertainty as to the assumption of continuity. In this regard please note that there are no negative indicators, such as, by way of example, those identified in Document 570, “Company Continuity”, recommended by CONSOB resolution n° 16231 on November 21 2007. With reference to the provisions of art. 6, chap. 2 of Banca d’Italia’s July 31 1992 order, and on the basis of the provisions of section 2428 of the Civil Code, please note the following: a) Research and development: the company did not conduct Research and Development during the year. b) Number and face value of own stocks and shares and those of the parent company in portfolio: the company has never directly or indirectly owned its own shares or shares in parent companies. c) Predictable management trends: a process of analysis of other European markets is underway, particularly the Turkish market, in relation to which the 129 Financial Statement 2008 - Management Report company, in close collaboration with the international area of the UBI Banca Group, will in the first half of 2009 proceed to investigate the possibility of forming business alliances with local counterparts in order to offer financial services to a shared clientele and other customers for import, export and domestic factoring activities. d) New organisational structure: consistently with the guidelines set forth in the “2007-2010 Industrial Plan for Integration”, on May 28 2008 the company’s Board of Directors resolved on a new organisational structure, which was gradually applied in the course of the second half of 2008 and which went into effect in full swing in October 2008. This organisational structure recently found its full expression in the establishment of an independent Compliance organisation with the features required by Banca d’Italia.
Recommended publications
  • Download Original Attachment
    2017 IIF Annual Membership Meeting List of Participants 10/04/2017 1 International Fincentre Associates Aberdeen Asset Management Aberdeen Standard Investments Aberdeen Standard Investments Abraaj Capital Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Global Market Abu Dhabi Investment Authority Abu Dhabi Investment Authority Abu Dhabi Investment Authority Abu Dhabi Investment Authority Access Bank Plc Access Bank Plc Access Bank Plc Access Bank Plc Acreditus Aflac Global Investments Aflac Global Investments Aflac International Aflac International AFME Africa Finance Corporation African Export Import Bank Page 1 of 51 2017 IIF Annual Membership Meeting List of Participants 10/04/2017 African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank African Export Import Bank Agricultural Bank of China, New York Branch Agricultural Bank of China, New York Branch AIG AIG AIIB Akbank Akbank Aker International AG Al Ahli Bank of Kuwait K.S.C.P Al Ahli Bank of Kuwait K.S.C.P Al Rajhi Bank Alawwal Bank Alawwal Bank Alawwal Bank Alawwal Bank Alawwal Bank Albaraka Turk Participation Bank Albaraka Turk Participation Bank Albaraka Turk Participation Bank Page 1 of 51 2017 IIF Annual Membership Meeting List of Participants 10/04/2017 Algebris Investments AllianceBernstein L.P.
    [Show full text]
  • Global Mergers & Acquisitions Review
    Global Mergers & Acquisitions Review FIRST HALF 2020 | FINANCIAL ADVISORS Global Mergers & Acquisitions Review First Half 2020 | Financial Advisors Global Deals Intelligence Global Announced M&A $4,500 30,000 WORLDWIDE DEAL MAKING FALLS 41%; LOWEST FIRST HALF SINCE 2013 Worldwide M&A activity totaled US$1.2 trillion during the first half of 2020, a decrease of 41% compared $4,000 to year-ago levels and the slowest opening six-month period for mergers & acquisitions since the first 25,000 half of 2013. The second quarter of 2020 registered a 25% decrease compared to the first quarter of the year and marks the slowest quarter of deal making since the first quarter of 2012. By number of $3,500 worldwide deals, deal making declined 16% compared to year ago levels, a six-year low. $3,000 20,000 CROSS-BORDER M&A DECLINES 15% TO SEVEN-YEAR LOW $2,500 Cross-border M&A activity totaled US$440.7 billion during the first half of 2020, a 15% decrease 15,000 compared to a year ago and the slowest first half for cross-border M&A since 2013. The Industrials, $2,000 Technology and Energy and Power sectors accounted for 37% of cross-border deals during the first half of 2020, down from 40% a year ago. $1,500 10,000 US TARGET M&A DECLINES 69%, LOWEST PERCENTAGE OF TOTAL M&A ON RECORD $1,000 M&A activity for US targets totaled US$354.9 billion during the first half of 2020, a decrease of 69% 5,000 compared to the level of activity seen during the first half of 2019 and the lowest opening six-month $500 period for US deal making since 2012.
    [Show full text]
  • PEI 300 Guess Who’S Back on Top?
    Issue 165 | May 2018 | privateequityinternational.com PEI 300 Guess who’s back on top? THE ORACLE SPEAKS David Rubenstein on the future of private capital SECONDARIES ROUNDTABLE Keeping LPs front and centre WHY PRIVATE EQUITY? The asset allocation special PLUS: the PEI Q1 Fundraising Report; IRRs vs money multiples; introducing the CEPRES model portfolio; Texas TRS goes Canadian; inside the PE retail blowouts; and much more… Equistone announced the successful final We are one of close of Fund VI at its €2.8bn hard cap in March 2018. Europe’s most Equistone has made three investments for Fund VI and will continue to source deals active mid-market and build value with management teams across our target markets. investors. www.equistonepe.com Evercore acted as the exclusive global placement agent for Equistone Partners Europe Fund VI. © EQUISTONE PARTNERS EUROPE LIMITED Authorised and regulated by The Financial Conduct Authority. PE International Ad May 2018.indd 1 18/04/2018 15:18 Riding high historically it’s been successful, but it needs to ISOBEL ISSN 1474–8800 | ISSUE 165 | MARKHAM work hard to avoid becoming a victim of that MAY 2018 EDITOR'S success. The signs are already there that this LETTER is starting to happen. Senior Editor, Private Equity Toby Mitchenall Tel: +44 207 566 5447 Sandra Robertson, chief investment officer [email protected] and chief executive of the UK’s £3 billion ($4.3 Americas Editor, Private Equity Marine Cole billion; €3.4 billion) Oxford University Endow- Tel: +1 212 633 1455 [email protected] ment
    [Show full text]
  • Equity Investment People's Republic of China: China Everbright Bank
    Extended Annual Review Report Reference Number: 30704 April 2009 Equity Investment People’s Republic of China: China Everbright Bank In accordance with ADB's public communications policy (PCP, 2005), this extended annual review report excludes information referred to in paragraph 126 of the PCP. CURRENCY EQUIVALENTS Currency Unit – yuan (CNY) At Appraisal At Project Completion 14 September 1996 13 December 2007 CNY1.00 = $0.1204 $0.1355 $1.00 = CNY8.3052 CNY7.3785 ABBREVIATIONS ADB – Asian Development Bank BOC – Bank of China CAGR – compound annual growth rate CAR – capital adequacy ratio CBRC – China Banking Regulatory Commission CCB – city commercial bank CEB – China Everbright Bank CEG – China Everbright Group CIB – China Investment Bank EROIC – economic return on invested capital FIRR – financial internal rate of return GDP – gross domestic product ICBC – Industrial and Commercial Bank of China IFC – International Finance Corporation IFRS – International Financial Reporting Standard IPO – initial public offering NAV – net asset value NPL – nonperforming loan PBOC – People’s Bank of China PRC – People’s Republic of China PSOD – Private Sector Operations Department RCC – rural credit cooperative ROIC – return on invested capital SME – small and medium-sized enterprises SOCB – state-owned commercial bank SOE – state-owned enterprise TA – technical assistance WACC – weighted average cost of capital NOTE In this report, "$" refers to US dollars Vice-President X. Zhao, Operations Group 1 Director General P. Erquiaga, Private Sector Operations Department (PSOD) Director R. van Zwieten, Capital Markets and Financial Sector Division, PSOD Team leader M. E. Paterno, Investment Specialist, PSOD Team members B. Huang, Young Professional, PSOD I. Chua, Investment Officer, PSOD CONTENTS Page EXECUTIVE SUMMARY i I.
    [Show full text]
  • Asset Atlas 1H20 Global Deal Advisory Financial Services Asset
    Asset Atlas 1H20 Global Deal Advisory Financial Services KPMG International home.kpmg October 2020 Introduction Welcome to the 27th edition of our Asset Atlas This bi-annual document prepared by the Global Deal Advisory Financial Services network gives an overview of merger and acquisition trends in the global financial services sector with a detailed analysis of potential opportunities. We examine M&A trends in various sub-sectors such as banking, insurance, asset management and private equity within financial services for 1H20 while shedding light on recent deal activity. Additionally, we consider available FS opportunities/assets as identified by KPMG across the globe. I believe it is an essential read for FS professionals and can serve as an effective M&A/business development tool and provides an insightful summary for decision makers across Financial Services in Corporate Development and M&A roles. Best regards, Giuseppe Rossano Latorre Global Financial Services Deal Advisory Lead KPMG International T: +39 02 6764 3918 M: +39 348 3055080 E: [email protected] ©2020 Copyright owned by one or more of the KPMG International entities. KPMG International entities provide no services to clients. All rights reserved. Contents Executive summary 04 Global financial services M&A 1H20 06 — Overview — Top deals — Deal type — Potential assets Banking M&A 1H20 11 — Deal statistics and trends — Top deals and key corridors — Potential opportunities — Trading multiple of major banks Insurance M&A 1H20 16 — Deal statistics and trends — Top deals and key corridors — Potential opportunities — Trading multiple of major insurers Asset management M&A 1H20 21 — Deal statistics and trends — Top deals and key corridors — Potential opportunities — AuM analysis of major investment managers Private equity M&A 1H20 26 — Deal statistics and trends — Areas of investment Contacts 30 Methodology 33 ©2020 Copyright owned by one or more of the KPMG International entities.
    [Show full text]
  • Banks and Investors Against Future: NGO Research Reveals Top Financiers of New Coal Power Development
    Media Briefing & Press Conference Banks and Investors Against Future: NGO Research Reveals Top Financiers of New Coal Power Development Japanese and European banks top lenders, Chinese banks top underwriters US companies biggest institutional investors in the coal plant pipeline Madrid | December 5, 2019 Urgewald, BankTrack and 30 partner NGOs publish new research identifying the top financiers and investors behind the expansion of the world’s coal plant fleet. Following today’s release of the data, Urgewald, BankTrack and further NGO partners will discuss findings and provide further insights at a panel dis- cussion and a press conference at the UN Climate Summit on Saturday, Dec 7th at 11:30am and Monday, Dec 9th at 5:30pm. “The UN Secretary General, the IPCC and climate scientists worldwide have ti- me and again called for a speedy phase-out of coal-based energy production, but most financial institutions are still turning a deaf ear. Over the past 3 years, financial institutions have channeled US$ 745 billion to companies planning new coal power plants,” says Heffa Schuecking, director of Urgewald. The NGOs’ data covers both lending and underwriting between January 2017 and September 2019 for all 258 coal plant developers identified on Urgewald’s Global Coal Exit List. Altogether, there are still over 1,000 new coal power sta- tions or units in the pipeline. If built, these projects would add 570 GW to the global coal plant fleet, an increase of 28%. “Most of the top banks providing loans or investment banking services to the- se companies acknowledge the risks of climate change, but their actions are a slap in the face to the Paris Climate Agreement,” says Greig Aitken, climate campaigner at BankTrack.
    [Show full text]
  • Interim Report for the Six Months Ended 30 June 2008
    China Everbright Limited 中國光大控股有限公司 (Stock Code: 165) Interim Report For the six months ended 30 June 2008 簡單成就價值 Making Wealth Simple BOARD OF DIRECTORS Tang Shuangning Chairman Zang Qiutao Deputy Chairman Chen Shuang Chief Executive Officer Tang Chi Chun, Richard Chief Financial Officer + Wang Weimin * Ng Ming Wah, Charles * Seto Gin Chung, John * Lin Zhijun + Non-executive Director * Independent Non-executive Directors COMPANY SECRETARY LEGAL ADVISOR Chan Ming Kin Messrs. Wilkinson & Grist REGISTERED OFFICE SHARE REGISTRARS Room 4001, 40th Floor Tricor Secretaries Limited Far East Finance Centre 26th Floor, Tesbury Centre 16 Harcourt Road 28 Queen’s Road East Hong Kong Wanchai Hong Kong PRINCIPAL BANKERS AUDITORS Standard Chartered Bank (Hong Kong) Limited KPMG Bank of Communications Company, Limited Fubon Bank (Hong Kong) Limited Hang Seng Bank Limited WEBSITE ADDRESS http://www.everbright165.com.hk STOCK CODE: 165 China Everbright Limited Interim Report 2008 1 INTERIM RESULTS The Directors of China Everbright Limited (the “Company”) are pleased to announce the unaudited results of the Company and its subsidiaries (the “Group”) for the six months ended 30 June 2008. The interim financial report is prepared on a basis consistent with the accounting policies and methods adopted in the 2007 audited accounts. The interim financial report is unaudited, but has been reviewed by KPMG, in accordance with Hong Kong Standard on Review Engagements 2410, “Review of interim financial information performed by the independent auditor of the entity” issued by the Hong Kong Institute of Certified Public Accountants, KPMG’s review report to the Board of Directors of the Company is included on page 23.
    [Show full text]
  • Life Sciences and Healthcare
    Life Sciences and Healthcare Beijing Guangzhou Hong Kong Shanghai Shenzhen 27/F, North Tower 17/F, International Finance 26/F, One Exchange Square 24/F, HKRI Centre Two, 17/F, Tower One, Kerry Plaza Beijing Kerry Centre Place, 8 Huaxia Road, 8 Connaught Place, Central HKRI Taikoo Hui 1 Zhong Xin Si Road 1 Guanghua Road Zhujiang New Town Hong Kong 288 Shi Men Yi Road Futian District Chaoyang District Guangzhou 510623, China Shanghai 200041, China Shenzhen 518048, China Beijing 100020, China Tel: +86 10 5769 5600 Tel: +86 20 3225 3888 Tel: +852 3976 8888 Tel: +86 21 2208 1166 Tel: +86 755 8159 3999 Fax:+86 10 5769 5788 Fax:+86 20 3225 3899 Fax:+852 2110 4285 Fax:+86 21 5298 5599 Fax:+86 755 8159 3900 www.fangdalaw.com Life Sciences and Healthcare Life Sciences and Healthcare 01 The Preeminent China-based International Law Firm Founded in 1993 and one of the most prestigious law firms Our service to clients is premised on the dual foundations in the region, Fangda Partners has over 700 lawyers. We of strong local law capabilities and a global business outlook. serve a wide variety of major clients – including large MNCs, Our lawyers are qualified in many jurisdictions, including global financial institutions, leading Chinese enterprises the People's Republic of China, Hong Kong SAR, England and fast-growing Hi-tech companies – on an extensive range and Wales, the United States, Singapore and Australia. of commercial matters through our network offices in Beijing, Guangzhou, Hong Kong, Shanghai and Shenzhen, Our understanding of the laws and processes in major offering PRC law and Hong Kong law.
    [Show full text]
  • Everbright Investment Conference 2014 Held in Xiamen
    Everbright Investment Conference 2014 held in Xiamen More than 350 investors and industry experts participate to discuss investment opportunities exhibited locally and abroad On 29-31 October 2014, China Everbright Limited (“Everbright”, stock code: 165.HK) held the Everbright Investment Conference 2014 in Xiamen to explore the current economic development trends in China as well as investment opportunities and challenges China faces in the asset management industry, attracting a total of more than 350 investors and industry experts to participate in it. “Venturing Beyond Your Horizon” was the theme for the Investment Conference. Industry experts congregated to discuss the in-depth development trend of China’s economy and the asset management industry as well as to provide a comprehensive analysis of where China is situated in the global asset management market and the challenges to overcome. They explored how China can advance in the international capital market as well as further grasp global investment opportunities and to discover how to attract overseas capital into the Chinese market to further spring the momentum of China’s economic development. The conference began with a welcome remarks and opening speech by Everbright’s Executive Director and CEO Mr. Chen Shuang, followed by a keynote speech by Deputy General Manager of China Everbright Group Limited and Deputy Chairman of the Board of Directors of China Everbright Limited Dr. Liu Jun, and The National Council for Social Security Fund’s Vice-Chairman, Mr. Wang Zhongmin, talking about financial crisis and risk management as well as the economic ecosystem of internet investment. Mr. Chen Shuang, together with Sequoia Capital China’s Founding Managing Partner, Mr.
    [Show full text]
  • Everbright Securities Company Limited 光大證券股份有限公司 (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability) (Stock Code: 6178)
    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Everbright Securities Company Limited 光大證券股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 6178) ANNOUNCEMENT OF annual RESULTS FOR THE YEAR ENDED DECEMBER 31, 2018 The board of directors (the “Board”) of Everbright Securities Company Limited (the “Company”) hereby announces the audited annual results of the Company and its subsidiaries (the “Group”) for the year ended December 31, 2018. This announcement, containing the full text of the 2018 annual report of the Company, complies with the relevant requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited in relation to information to accompany preliminary announcement of annual results. The Group’s final results for the year ended December 31, 2018 have been reviewed by the audit committee of the Company. This results announcement will be published on the website of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk) and the Company’s website (www.ebscn.com). The Company’s 2018 annual report will be dispatched to the holders of H shares of the Company and published on the websites of The Stock Exchange of Hong Kong Limited and the Company in due course.
    [Show full text]
  • View Annual Report
    STEALTH BIOTHERAPEUTICS CORP FORM 20-F (Annual and Transition Report (foreign private issuer)) Filed 04/04/19 for the Period Ending 12/31/18 Telephone 617-600-6888 CIK 0001696396 Symbol MITO SIC Code 2834 - Pharmaceutical Preparations Industry Biotechnology & Medical Research Sector Healthcare Fiscal Year 12/31 http://www.edgar-online.com © Copyright 2020, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number: 001-38810 STEALTH BIOTHERAPEUTICS CORP (Exact name of Registrant as specified in its charter) N/A (Translation of Registrant’s name into English) Cayman Islands (Jurisdiction of incorporation) Stealth BioTherapeutics Corp c/o Intertrust Corporate Services (Cayman) Limited 190 Elgin Avenue, George Town Grand Cayman KY1-9005 Cayman Islands (address of principal
    [Show full text]
  • EMPEA Brief the Evolution of PE in China
    Periodic Research on Important Developments and Trends in EM PE April 2012 EMPEA Brief The Evolution of PE in China This EMPEA Brief is a primer on the history and development of China’s domestic private equity industry, and provides an overview of local currency (RMB) fund managers—both foreign and domestic—operating in the country. It is a reprint of “The Evolution and Future of Private Equity in China,” authored by EMPEA CEO Sarah Alexander and Senior Associate Mike Casey, which ran in the March 2012 issue of the Emerging Markets Private Equity Review. Introduction Clarification of the types of private equity funds active in China, including delineation of institutional quality fund There may be no better symbol of the evolution of private managers, will facilitate further capital flows—domestic equity in China than Chinese fund manager Hony Capital’s and foreign—into the market. The article closes by explor- announcement in January 2012 that it successfully raised ing three trends likely to shape the future of private equity US$4 billion in capital for two new funds—US$2.4 billion in China: growing demand for the asset class; increasing for its fifth USD-denominated fund and RMB10 billion levels of local LP participation; and, professionalization (US$1.6 billion) for its second local currency (RMB) fund. paving the way for local Chinese investors to pursue cross- Hony Capital illustrates the profound transformations that border and international opportunities. have taken place in China in the last decade, including the rise of professional domestic fund managers, the growth of Background RMB funds and the development of China’s LP base.
    [Show full text]